BridgeBio smashes sales forecasts Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 30 April, 2025

Who are the LGBTQ+ leaders in the industry? Hear insights from the honorees giving voice and visibility to the LGBTQ+ presence in biopharma — join virtually and celebrate with us. Sign up now.

presented by Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

spotlight How pharma is reacting to ‘Liberation Day’: Join us tomorrow for Post-Hoc Live!

news Novartis to buy Regulus Therapeutics for up to $1.7B GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says BridgeBio’s Attruby outperforms sales expectations, shares rise Artios drug exploits ‘replication stress’ in cancer, shrinking subset of tumors in early study

VP, Clinical Development / CMO / CDO‬ Autonomy Bio Inc. San Francisco, CA 94107, USA COO / Head of Operations Autonomy Bio Inc. San Francisco, CA 94107, USA ‭ Regulatory Lead / Head of Regulatory‬ Autonomy Bio Inc. San Francisco, CA 94107, USA Research Associate I/II - Gene Therapy MeiraGTx New York, NY, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

Exploring Japan as a key market for your drug? Get the roadmap — join senior Japanese leaders to hear firsthand on the regulatory and pricing dynamics behind one of the world’s top pharma markets. Sign up now.

endpoints pharma Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies FDA won't reorganize medical product centers, Makary says in interview: 'I rejected that proposal' Merck plans to bring Keytruda production to the US with $1B biologics factory

May 12 1:30pm ET How to incorporate pragmatic design elements into your clinical studies sponsored by Flatiron May 29 10:30am ET Optimizing the clinical research workforce - An industry analysis by Parexel sponsored by Parexel

in case you missed it 1. Pfizer launches a new wave of cost cuts, expects $7.7B in total savings through 2027 2. With a new CEO, oligonucleotide biotech Creyon forges Eli Lilly partnership 3. FDA delays PDUFA date for small biotech, raising questions about impact of agency cuts 4.